United Kingdom · Biopharma startup
United Kingdom · Genomics
Genomics plc aiming to lead the genomic transformation of healthcare.
Funding reportedLast round: Series C
Follow Genomics and see its new rounds in your feed.Start following
What company datasets say Genomics raised
Funding, as reported
Reported in all135.4Min the source's currency
Rounds8
Last roundSeries C
Last round dateJan 2024
Investors listed16
Funding filed with regulators
Genomics filed 5 raises, $49M in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2024$165KUK share allotment
- Jan 2024$43MUK share allotment
- Oct 2022$709KUK share allotment
- Oct 2021$1.6MUK share allotment
- Jun 2021$3.8MUK share allotment
Founders and team
From Genomics's own website: 14 on the team.
- David ThorntonPresident
- Alex EavisChief Product and Technology Officer
- Catherine YongChief of Staff
- Dr. Seamus HarrisonChief Medical Officer
- Dr. Vincent PlagnolChief Scientific Officer
- Sneha BakshiChief People & Operations Officer
- Michaela BroadhurstHead of Corporate Development
- Alex PasteurBoard Member
- Dr Jim TananbaumDirector
- Dr Jose-Carlos Gutiérrez-RamosBoard Member
- Dr Sam WilliamsDirector
- Kristin HerreraIndependent Non-Executive Director
- Professor Dame Sally DaviesIndependent Non-Executive Director
- Simon DingemansChairman of the Board
On 3 portfolio pages
Investors who name them
Each firm lists Genomics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Genomics in front of investors. Or tell us what we have wrong.